ACCELERON PHARMA INC. Temporary Equity, Accretion to Redemption Value, Adjustment
ACCELERON PHARMA INC. reported Temporary Equity, Accretion to Redemption Value, Adjustment of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment · last filed 2016-02-25
- ACCELERON PHARMA INC. temporary equity, accretion to redemption value, adjustment for the quarter ending 2014-12-31 was $0.00.
- ACCELERON PHARMA INC. temporary equity, accretion to redemption value, adjustment for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- ACCELERON PHARMA INC. temporary equity, accretion to redemption value, adjustment for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- ACCELERON PHARMA INC. temporary equity, accretion to redemption value, adjustment for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- ACCELERON PHARMA INC. temporary equity, accretion to redemption value, adjustment for fiscal 2015 was $0.00.
- ACCELERON PHARMA INC. temporary equity, accretion to redemption value, adjustment for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- ACCELERON PHARMA INC. temporary equity, accretion to redemption value, adjustment for fiscal 2013 was $19.87M, a 26.57% decline from fiscal 2012.
- ACCELERON PHARMA INC. temporary equity, accretion to redemption value, adjustment for fiscal 2012 was $27.06M, a 24.38% increase from fiscal 2011.
| Period end | Temporary Equity, Accretion to Redemption Value, Adjustment 3 month | Temporary Equity, Accretion to Redemption Value, Adjustment 6 month | Temporary Equity, Accretion to Redemption Value, Adjustment 9 month | Temporary Equity, Accretion to Redemption Value, Adjustment 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-25 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $0.00 10-K · filed 2016-02-25 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $0.00 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-12 | $0.00 10-Q · filed 2014-08-12 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $6.27M derived: sum of 2 quarters · filed 2016-02-25 | $13.12M derived: sum of 3 quarters · filed 2016-02-25 | $19.87M 10-K · filed 2016-02-25 |
| 2013-09-30 | $6.27M 10-Q · filed 2014-11-07 | $13.12M derived: sum of 2 quarters · filed 2014-11-07 | $19.87M 10-Q · filed 2014-11-07 | $26.64M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $6.84M 10-Q · filed 2014-08-12 | $13.60M 10-Q · filed 2014-08-12 | $20.37M derived: sum of 3 quarters · filed 2015-03-02 | $27.11M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $6.76M 10-Q · filed 2014-05-15 | $13.52M derived: sum of 2 quarters · filed 2015-03-02 | $20.27M derived: sum of 3 quarters · filed 2015-03-02 | |
| 2012-12-31 | $6.77M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $13.52M derived: sum of 2 quarters · filed 2015-03-02 | $27.06M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $6.75M 10-Q · filed 2013-11-14 | $20.29M 10-Q · filed 2013-11-14 | ||
| 2011-12-31 | $21.76M 10-K · filed 2014-03-17 |